Flavonoids, Breast Cancer Prevention, and Its Treatment: A Growing Evidence
Open Access
- 10 January 2025
- journal article
- Published by Sciencedomain International in Journal of Cancer and Tumor International
- Vol. 15 (1) , 38-59
Abstract
There is mounting evidence linking certain lifestyle factors such as food, weight, and physical activity to an increased risk of breast cancer. Flavonoids are commonly used in traditional medicine. Plenty of studies have investigated the relationship between flavonoid consumption and breast cancer in humans. This review aimed to examine the association between flavonoids, each flavonoid subclass and the risk of breast cancer besides therapeutic use of flavonoids to break the multidrug resistance in breast cancer. Prospective cohort, case-control, and laboratory-based studies published between around 1990’s to date and referred to the impact of flavonoids on breast cancer prevention, treatment, or other roles were included. Odd Ratio (OR)/ Risk Ratio (RR) and Hazard ratio (HR) along 95% confidence interval (CI) were carefully reviewed to reveal the association between different subgroups of flavonoids and breast cancer risk. Other adjustments (e.g. age, menopausal status, food habits, race, BMI, etc.) were also considered. The antioxidant properties of flavonoids, as well as their ability to inhibit apoptosis, suppress estrogen activity, and limit the proliferation of breast cancer cells, all contribute to a significant reduction in the risk of developing breast cancer. There are linings enough that some polyphenolic compounds are effective as drugs for treating breast cancer.Keywords
This publication has 64 references indexed in Scilit:
- Ki‐67 index, progesterone receptor expression, histologic grade and tumor size in predicting breast cancer recurrence risk: A consecutive cohort studyCancer Communications, 2020
- Mutant p53 in breast cancer: potential as a therapeutic target and biomarkerBreast Cancer Research and Treatment, 2018
- Apigenin, a dietary flavonoid, induces apoptosis, DNA damage, and oxidative stress in human breast cancer MCF-7 and MDA MB-231 cellsNaunyn-Schmiedeberg's Archives of Pharmacology, 2018
- Quercetin is a potent anti‐atherosclerotic compound by activation of SIRT1 signaling under oxLDL stimulationMolecular Nutrition & Food Research, 2015
- Total dietary antioxidant capacity, individual antioxidant intake and breast cancer risk: The Rotterdam studyInternational Journal of Cancer, 2014
- Luteolin induces apoptosis in multidrug resistant cancer cells without affecting the drug transporter function: Involvement of cell line‐specific apoptotic mechanismsInternational Journal of Cancer, 2011
- Phytoestrogens as natural prodrugs in cancer prevention: dietary flavonoidsPhytochemistry Reviews, 2009
- Dietary flavonoid intake and risk of cancer in postmenopausal women: The Iowa Women's Health StudyInternational Journal of Cancer, 2008
- Dietary phytoestrogen intake—lignans and isoflavones—and breast cancer risk (Canada)Cancer Causes & Control, 2007
- Inhibition of Neoplastic Transformation and Bioavailability of Dietary Flavonoid Agents1998